Work

Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment

Year: 2022

Type: article

Abstract: This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications.

Source: JAMA Surgery

DOI: 10.1001/jamasurg.2022.3922

Authors: Thomas J. Handley, Katherine Arnow, Kazunari Sasaki, Allison Kwong, Marc L. Melcher

Institutions: Stanford Medicine, Stanford University

Language: English

Topic: Organ Transplantation Techniques and Outcomes

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4302009405

FWCI: 0.477

Cites: 4

Cited by: 2

Related to: 10